Publisher | Google Scholor Zhang Y, Zhu X, Yu X, Novk P, Gui Q, et al
At BW Primary Care, we want every patient, whether you are on Medicare or not, to understand what this program is, how it works, who it helps, and how our practice is preparing to support you through the rollout
Lancet 1, 1251
Constipation: This is also reported more frequently with the oral version than the injectable
If you feel that the severity of your emotional side effects is high and the duration has been persistent immediately see your provider. A healthcare provider can help with weighing the benefits youre getting from GLP-1 medications against any emotional side effects you may be experiencing potentially adjusting dosage or medication type and recommending additional mental health support, if needed
August 2025 On August 1, 2025, the JPML reported there are 2,190 cases pending in MDL -3094 IN RE: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation